Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co FCF Growth

The Year-over-Year Free Cash Flow Growth of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 19, 2026 is 10.60 %. In the previous year, Year-over-Year Free Cash Flow Growth was 533.52 % — a change of -98.01% (lower).

FCF Growth

10.60 %

YoY

-98.01%

Last updated:

Year-over-Year Free Cash Flow Growth of Shanghai Rendu Biotechnology Co is 2025 10.60 % . Year-over-Year Free Cash Flow Growth of Shanghai Rendu Biotechnology Co was 2024 533.52 % . It decreases by -98.01% lower compared to the previous year.

The Shanghai Rendu Biotechnology Co FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2019
-334.31 CNY
Jan 1, 2020
287.22 CNY
Jan 1, 2021
-63.71 CNY
Jan 1, 2022
-190.49 CNY
Jan 1, 2023
87.36 CNY
Jan 1, 2024
533.52 CNY
Jan 1, 2025
10.60 CNY
The Shanghai Rendu Biotechnology Co FCF Growth history
YEARFCF GrowthYoY
10.60 %-98.01%
533.52 %+510.69%
87.36 %-145.86%
-190.49 %+199.00%
-63.71 %-122.18%
287.22 %-185.91%
-334.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co Ltd develops molecular diagnostic tests using RNA isothermal amplification technology, offering reagents for respiratory, reproductive, enterovirus, and blood-borne disease diagnostics. Headquartered in Shanghai, China, the company employs 528 full-time staff and operates primarily within the domestic market. Listed on March 30, 2022, it designs and manufactures medical instruments alongside its diagnostic products. Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Year-over-Year Free Cash Flow Growth of Shanghai Rendu Biotechnology Co is 10.60 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Shanghai Rendu Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Shanghai Rendu Biotechnology Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Shanghai Rendu Biotechnology Co